Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579865 · ClinicalTrials.gov registry record
Quality Of Life in Patients With Malignant Biliary Obstruction
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 124
- Enrollment target
NCT00579865: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00579865 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579865 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
You may have symptoms like itching, abdominal pain, loss of appetite, fatigue, fevers and chills. The treatment you will receive to relieve the blockage is also intended to relieve symptoms and improve your quality of life. The purpose of this study is to find out if relieving the blockage in your bile duct improves your quality of life.
Interventions
- BEHAVIORAL questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2005-05 |
| Est. Completion | 2010-01 |
What the finished NCT00579865 record still lists
NCT00579865 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which questionnaires is the first listed.
NCT00579865 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00579865 about?
NCT00579865 is a clinical study titled "Quality Of Life in Patients With Malignant Biliary Obstruction". You may have symptoms like itching, abdominal pain, loss of appetite, fatigue, fevers and chills. The treatment you will receive to relieve the blockage is also intended to relieve symptoms and improve your quality of life. The purpose of this study is to find out if relieving the blockage in your b...
What is the current status of trial NCT00579865?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2005-05. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00579865?
The interventions under investigation include: questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00579865?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia